AU2011290126B2 - Heterocyclic compound and use thereof - Google Patents

Heterocyclic compound and use thereof Download PDF

Info

Publication number
AU2011290126B2
AU2011290126B2 AU2011290126A AU2011290126A AU2011290126B2 AU 2011290126 B2 AU2011290126 B2 AU 2011290126B2 AU 2011290126 A AU2011290126 A AU 2011290126A AU 2011290126 A AU2011290126 A AU 2011290126A AU 2011290126 B2 AU2011290126 B2 AU 2011290126B2
Authority
AU
Australia
Prior art keywords
optionally substituted
halogen atom
alkyl
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011290126A
Other languages
English (en)
Other versions
AU2011290126A1 (en
Inventor
Yasutomi Asano
Eiji Honda
Toshihiro Imaeda
Masakuni Kori
Michiyo Mochizuki
Shinji Nakamura
Masashi Toyofuku
Osamu Ujikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of AU2011290126A1 publication Critical patent/AU2011290126A1/en
Application granted granted Critical
Publication of AU2011290126B2 publication Critical patent/AU2011290126B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2011290126A 2010-08-10 2011-08-09 Heterocyclic compound and use thereof Active AU2011290126B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10
JP2010-179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Publications (2)

Publication Number Publication Date
AU2011290126A1 AU2011290126A1 (en) 2013-03-07
AU2011290126B2 true AU2011290126B2 (en) 2016-01-07

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011290126A Active AU2011290126B2 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Country Status (39)

Country Link
US (11) US9150591B2 (OSRAM)
EP (1) EP2603513B1 (OSRAM)
JP (2) JP5788496B2 (OSRAM)
KR (1) KR101852215B1 (OSRAM)
CN (2) CN103180326B (OSRAM)
AR (1) AR082618A1 (OSRAM)
AU (1) AU2011290126B2 (OSRAM)
BR (1) BR112013002250B1 (OSRAM)
CA (1) CA2807460C (OSRAM)
CL (1) CL2013000380A1 (OSRAM)
CO (1) CO6680700A2 (OSRAM)
CR (1) CR20130066A (OSRAM)
CY (1) CY1123507T1 (OSRAM)
DK (1) DK2603513T3 (OSRAM)
DO (1) DOP2013000030A (OSRAM)
EA (1) EA022078B1 (OSRAM)
EC (1) ECSP13012478A (OSRAM)
ES (1) ES2793723T3 (OSRAM)
GE (1) GEP20156216B (OSRAM)
HR (1) HRP20200844T1 (OSRAM)
HU (1) HUE049460T2 (OSRAM)
IL (1) IL224452A (OSRAM)
LT (1) LT2603513T (OSRAM)
MA (1) MA34509B1 (OSRAM)
MX (1) MX349470B (OSRAM)
MY (1) MY165908A (OSRAM)
NZ (1) NZ607593A (OSRAM)
PE (1) PE20131116A1 (OSRAM)
PH (1) PH12013500247A1 (OSRAM)
PL (1) PL2603513T3 (OSRAM)
PT (1) PT2603513T (OSRAM)
RS (1) RS60311B1 (OSRAM)
SG (1) SG187656A1 (OSRAM)
SI (1) SI2603513T1 (OSRAM)
TW (1) TWI504604B (OSRAM)
UA (1) UA111594C2 (OSRAM)
UY (1) UY33551A (OSRAM)
WO (1) WO2012020848A1 (OSRAM)
ZA (1) ZA201301120B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2603513T (lt) * 2010-08-10 2020-05-25 Takeda Pharmaceutical Company Limited Heterociklinis junginys ir jo panaudojimas kaip ampa receptoriaus teigiamo alosterinio moduliatoriaus
EP2694472B1 (en) * 2011-04-05 2020-03-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
JP6134654B2 (ja) * 2012-02-08 2017-05-24 武田薬品工業株式会社 複素環化合物およびその用途
JP2016521755A (ja) * 2013-06-13 2016-07-25 ヴェロサイエンス，リミテッド・ライアビリティー・カンパニー 代謝障害を治療するための組成物および方法
FI3421462T3 (fi) 2013-06-27 2023-06-26 Pfizer Heteroaromaattisia yhdisteitä ja niiden käyttö dopamiini-d1-ligandeina
MY181117A (en) 2013-12-03 2020-12-18 Fmc Corp Pyrrolidinone herbicides
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
EP3164386B1 (en) 2014-07-02 2020-10-07 FMC Corporation Piperidinone herbicides
SG11201702924WA (en) 2014-12-08 2017-05-30 Du Pont 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
RU2710379C2 (ru) 2015-04-10 2019-12-26 ЭфЭмСи Корпорейшн Замещенные циклические амиды в качестве гербицидов
EP3288928B1 (en) 2015-04-27 2021-10-13 FMC Corporation Butyrolactones as herbicides
DK3288940T5 (da) 2015-04-29 2021-09-20 Janssen Pharmaceutica Nv Azabenzimidazoler og deres anvendelse som ampa-receptormodulatorer
WO2016176457A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
CA2980643C (en) 2015-05-12 2023-10-17 E I Du Pont De Nemours And Company Aryl substituted bicyclic compounds as herbicides
JP6869192B2 (ja) 2015-05-29 2021-05-12 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 除草剤としての置換環状アミド
RU2017142979A (ru) 2015-06-02 2019-07-15 ЭфЭмСи Корпорейшн Замещенные циклические амиды и их применение в качестве гербицидов
JP6937290B2 (ja) 2015-07-31 2021-09-22 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 除草剤として有用な環状ｎ−カルボキサミド化合物
CN107709342B (zh) * 2015-08-06 2021-09-03 豪夫迈·罗氏有限公司 制备乙酰半乳糖胺酸衍生物的方法
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
CN110312712B (zh) 2016-12-21 2023-06-23 Fmc公司 硝酮除草剂
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用，药物组合物
JP7201609B2 (ja) 2017-03-21 2023-01-10 エフ エム シー コーポレーション ピロリジノン及びこれらを調製するためのプロセス
US11919859B2 (en) 2017-03-21 2024-03-05 Fmc Corporation Herbicidal mixture, composition and method
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
US11407748B2 (en) 2017-10-06 2022-08-09 Takeda Pharmaceutical Company Limited Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function
ES2971497T3 (es) 2017-10-06 2024-06-05 Takeda Pharmaceuticals Co Compuestos heterocíclicos
PH12022550597A1 (en) 2019-09-16 2024-03-04 Takeda Pharmaceuticals Co Azole-fused pyridazin-3(2h)-one derivatives
JP2023526249A (ja) * 2020-05-15 2023-06-21 武田薬品工業株式会社 うつ病の処置
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025226591A1 (en) 2024-04-22 2025-10-30 Neurocrine Biosciences, Inc. Methods of administering 9-[4-(cyclohexyloxy)phenyl]-7-methyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide without side effects

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH0437742A (ja) * 1990-06-03 1992-02-07 Konica Corp 新規な染料を含有するハロゲン化銀写真感光材料
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (OSRAM) 1986-10-22 1992-09-04
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
AU5271900A (en) 1999-11-04 2001-05-14 Colorado State University Research Foundation Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2005508352A (ja) 2001-10-10 2005-03-31 ニューロサーチ、アクティーゼルスカブ 新規ベンゾチアジン誘導体、その製造方法及びその使用方法
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2655376A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
MX2009006243A (es) * 2006-12-11 2009-08-12 Lilly Co Eli Potenciadores del receptor ampa.
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
CA2704698A1 (en) * 2007-11-05 2009-05-14 Schering Corporation Gamma secretase modulators
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
CA2718727A1 (en) 2008-03-25 2009-10-01 Takeda Pharmaceutical Company Limited Heterocyclic compound
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
CA2742602A1 (en) 2008-11-06 2010-05-14 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
CN102482276A (zh) 2009-07-13 2012-05-30 武田药品工业株式会社 杂环化合物及其用途
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
LT2603513T (lt) * 2010-08-10 2020-05-25 Takeda Pharmaceutical Company Limited Heterociklinis junginys ir jo panaudojimas kaip ampa receptoriaus teigiamo alosterinio moduliatoriaus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH0437742A (ja) * 1990-06-03 1992-02-07 Konica Corp 新規な染料を含有するハロゲン化銀写真感光材料
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CAS Registry No. 732959-59-0 *
WARD, S. E. et al., Current Medicinal Chemistry 2010, 17(30), 3503-3513 *

Also Published As

Publication number Publication date
US9884875B2 (en) 2018-02-06
US20120077799A1 (en) 2012-03-29
KR20130138738A (ko) 2013-12-19
PE20131116A1 (es) 2013-10-24
HRP20200844T1 (hr) 2020-08-21
ES2793723T3 (es) 2020-11-16
CA2807460C (en) 2018-09-18
US20170022222A1 (en) 2017-01-26
NZ607593A (en) 2015-01-30
KR101852215B1 (ko) 2018-04-25
US11279713B2 (en) 2022-03-22
WO2012020848A8 (en) 2012-09-27
BR112013002250A2 (pt) 2016-05-24
EP2603513A1 (en) 2013-06-19
US20190263832A1 (en) 2019-08-29
JP5788496B2 (ja) 2015-09-30
EP2603513B1 (en) 2020-03-11
US20140080817A1 (en) 2014-03-20
MY165908A (en) 2018-05-18
PT2603513T (pt) 2020-06-08
US9150591B2 (en) 2015-10-06
AR082618A1 (es) 2012-12-19
US20240360156A1 (en) 2024-10-31
US8916551B2 (en) 2014-12-23
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
US20150353578A1 (en) 2015-12-10
DOP2013000030A (es) 2013-03-15
LT2603513T (lt) 2020-05-25
US20200317692A1 (en) 2020-10-08
GEP20156216B (en) 2015-01-12
MX349470B (es) 2017-07-31
CA2807460A1 (en) 2012-02-16
ECSP13012478A (es) 2013-04-30
US20130184266A1 (en) 2013-07-18
JP2013535408A (ja) 2013-09-12
MA34509B1 (fr) 2013-09-02
EA022078B1 (ru) 2015-10-30
US9499568B2 (en) 2016-11-22
PH12013500247A1 (en) 2013-03-11
DK2603513T3 (da) 2020-06-15
CY1123507T1 (el) 2022-03-24
TWI504604B (zh) 2015-10-21
US8575154B2 (en) 2013-11-05
WO2012020848A1 (en) 2012-02-16
CL2013000380A1 (es) 2013-05-31
IL224452A (en) 2017-11-30
US10654874B2 (en) 2020-05-19
BR112013002250B1 (pt) 2020-10-27
RS60311B1 (sr) 2020-07-31
MX2013001614A (es) 2013-07-05
SG187656A1 (en) 2013-03-28
PL2603513T3 (pl) 2020-07-27
CN103180326A (zh) 2013-06-26
CO6680700A2 (es) 2013-05-31
UY33551A (es) 2012-03-30
CN104926837A (zh) 2015-09-23
EA201390222A1 (ru) 2013-08-30
CN103180326B (zh) 2015-06-10
US20130190291A1 (en) 2013-07-25
ZA201301120B (en) 2014-04-30
JP2016006080A (ja) 2016-01-14
HUE049460T2 (hu) 2020-09-28
AU2011290126A1 (en) 2013-03-07
US20150073137A1 (en) 2015-03-12
TW201217386A (en) 2012-05-01
US8778934B2 (en) 2014-07-15
JP6113789B2 (ja) 2017-04-12
US20180162875A1 (en) 2018-06-14
CR20130066A (es) 2013-05-03

Similar Documents

Publication Publication Date Title
US20240360156A1 (en) Heterocyclic compound and use thereof
WO2011036889A1 (ja) 複素環化合物
EP2813508B1 (en) Heterocyclic compound and use thereof
HK1182701B (en) Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator
HK1182701A (en) Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)